Fort L.P. Purchases Shares of 5,152 Innoviva Inc (INVA)
Fort L.P. purchased a new position in shares of Innoviva Inc (NASDAQ:INVA) in the fourth quarter, Holdings Channel reports. The fund purchased 5,152 shares of the biotechnology company’s stock, valued at approximately $90,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Oregon Public Employees Retirement Fund bought a new stake in shares of Innoviva during the fourth quarter worth approximately $26,000. Financial Gravity Companies Inc. bought a new stake in shares of Innoviva during the fourth quarter worth approximately $40,000. Quantamental Technologies LLC bought a new stake in shares of Innoviva during the fourth quarter worth approximately $172,000. Magnus Financial Group LLC bought a new stake in shares of Innoviva during the fourth quarter worth approximately $199,000. Finally, First Quadrant L P CA raised its stake in shares of Innoviva by 32.2% during the fourth quarter. First Quadrant L P CA now owns 14,558 shares of the biotechnology company’s stock worth $254,000 after buying an additional 3,546 shares during the last quarter. 77.77% of the stock is owned by institutional investors and hedge funds.
Several brokerages have commented on INVA. Zacks Investment Research downgraded shares of Innoviva from a “buy” rating to a “hold” rating in a research note on Tuesday, January 8th. BidaskClub downgraded shares of Innoviva from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 2nd. Finally, ValuEngine raised shares of Innoviva from a “sell” rating to a “hold” rating in a research note on Monday, February 25th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $16.50.
Shares of NASDAQ:INVA opened at $14.16 on Friday. Innoviva Inc has a 52 week low of $13.26 and a 52 week high of $20.54. The company has a quick ratio of 34.92, a current ratio of 34.92 and a debt-to-equity ratio of 2.41. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of 4.01 and a beta of 1.88.
Innoviva (NASDAQ:INVA) last issued its earnings results on Wednesday, February 6th. The biotechnology company reported $2.34 EPS for the quarter. The firm had revenue of $79.86 million during the quarter. Innoviva had a net margin of 151.36% and a negative return on equity of 508.18%. On average, research analysts anticipate that Innoviva Inc will post 1.43 EPS for the current year.
WARNING: “Fort L.P. Purchases Shares of 5,152 Innoviva Inc (INVA)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.dailypolitical.com/2019/03/17/fort-l-p-purchases-shares-of-5152-innoviva-inc-inva.html.
Innoviva, Inc engages in the development and commercialization of bio-pharmaceuticals. Its portfolio of respiratory products include RELVAR/BREO ELLIPTA, (fluticasone furoate/ vilanterol, FF/VI); ANORO ELLIPTA (umeclidinium bromide/ vilanterol, UMEC/VI); and TRELEGY ELLIPTA (the combination FF/UMEC/VI).
Featured Story: Why is cost of goods sold important?
Want to see what other hedge funds are holding INVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innoviva Inc (NASDAQ:INVA).
Receive News & Ratings for Innoviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innoviva and related companies with MarketBeat.com's FREE daily email newsletter.